ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 50273 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 50273; 2) Community: the network communities that were significantly associated with the response to NSC 50273; 3) Molecule: the relationships between components within communities and NSC 50273; 4) MDR: the compounds that were significantly associated with the NSC 50273.

NSC Compound Enrichment Correlation
NSC 268993 Deferoxamine hydrochloride 0.0407060322613564 0.25592435
NSC 289074 Null 0.0407060322613564 -0.068005203
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0407060322613564 0.29453076
NSC 302991 Camptothecin Derivative 0.0407060322613564 0.22579236
NSC 757933 1,3-diphenyl-4-(3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-1H-pyrazole 0.0422061523786544 -0.072232966
NSC 160127 2-Thia-1,3,5,7-tetraazaadamantane, 2,2-dioxide 0.0422061523786546 -0.015930888
NSC 369327 ELSAMICIN 0.0422061523786546 0.17646081
NSC 619311 Null 0.0422061523786552 -0.055180511
NSC 642740 4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy- 8-(3-hydroxy-1-methyl-4-piperidinyl)- 0.0422061523786552 0.10551167
NSC 643724 Null 0.0422061523786552 -0.0050595093
Total:106  Current:95    [First] [Prev] [Next] [Last]